View in EDS PDF Full Text

Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.

Saved in:
Bibliographic Details
Title: Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.
Authors: Stoler-Barak L; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Petrovich E; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Aychek T; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Gurevich I; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Tal O; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Hatzav M; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Ilan N; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Feigelson SW; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Shakhar G; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Vlodavsky I; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Alon R; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel ronen.alon@weizmann.ac.il.
Source: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2015 May; Vol. 29 (5), pp. 2010-21. Date of Electronic Publication: 2015 Jan 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25634957
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stoler-Barak+L%22">Stoler-Barak L</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Petrovich+E%22">Petrovich E</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Aychek+T%22">Aychek T</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Gurevich+I%22">Gurevich I</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Tal+O%22">Tal O</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Hatzav+M%22">Hatzav M</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Ilan+N%22">Ilan N</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Feigelson+SW%22">Feigelson SW</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Shakhar+G%22">Shakhar G</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Vlodavsky+I%22">Vlodavsky I</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Alon+R%22">Alon R</searchLink>; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel ronen.alon@weizmann.ac.il.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228804484%22">FASEB journal : official publication of the Federation of American Societies for Experimental Biology</searchLink> [FASEB J] 2015 May; Vol. 29 (5), pp. 2010-21. <i>Date of Electronic Publication: </i>2015 Jan 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Federation+of+American+Societies+for+Experimental+Biology%22">Federation of American Societies for Experimental Biology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8804484 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1530-6860 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208926638%22">08926638 </searchLink><i>NLM ISO Abbreviation: </i>FASEB J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25634957
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1096/fj.14-265447
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2010
    Titles:
      – TitleFull: Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stoler-Barak L
      – PersonEntity:
          Name:
            NameFull: Petrovich E
      – PersonEntity:
          Name:
            NameFull: Aychek T
      – PersonEntity:
          Name:
            NameFull: Gurevich I
      – PersonEntity:
          Name:
            NameFull: Tal O
      – PersonEntity:
          Name:
            NameFull: Hatzav M
      – PersonEntity:
          Name:
            NameFull: Ilan N
      – PersonEntity:
          Name:
            NameFull: Feigelson SW
      – PersonEntity:
          Name:
            NameFull: Shakhar G
      – PersonEntity:
          Name:
            NameFull: Vlodavsky I
      – PersonEntity:
          Name:
            NameFull: Alon R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2015 May
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1530-6860
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
              Type: main
ResultId 1